Overview
smartADHERE*
Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Objective
To evaluate the effectiveness of an intervention with a mobile adherence platform, compared to physician - or nurse - guided standard of care, to improve medication adherence to rivaroxaban in subjects who have recently initiated treatment with rivaroxaban for stroke prevention in atrial fibrillation based on an assessment of the PDC, (proportion of days covered) of rivaroxaban treatment.
Study Coordinator(s)
Stephanie Porenta, RN: 425.467.3986, Stephanie.Porenta@overlakehospital.org
Complete the online contact information form.
Learn More
Principal Investigator(s)
Clinical Trial Categories
Cardiovascular
*NOTE: THIS TRIAL IS NO LONGER ACCEPTING NEW PATIENTS.